kidney-stone-management-devices-market

Kidney Stone Management Devices Market By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy (PCNL)) Growth, Share, Opportunities & Competitive Analysis, 2016 -2024

25 May 2016 Format PDF icon PPT icon XLS icon Request Sample

Urolithiasis or kidney stone is one of the most common renal conditions. The annual incidence of kidney stones in the industrialized world is 0.2%. In the U.S. the lifetime prevalence of the disease is 12% for men and 7% for women; whereas, familial history further increases the risk. Lifetime risk of kidney stones is 20% for Saudi Arabia, 8% -15% for the Western world and 2% to 5% for Asia.

For the purpose of this study, the global kidney stone management devices market is studied for devices and equipment used in treatments such as extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy (PCNL), and related accessories. Market size and forecast for each of these segments for the period 2014-2023 (in terms of USD Mn) along with respective CAGRs for the forecast period 2016-2023 are provided in this report.

Market size and forecast for these regional and country level markets are presented in this study for the period 2014-2023. Market growth rates for the forecast period 2016-2023 are also included in this report, considering 2015 as the base year. In addition to the cumulative market size and forecast, this section also includes market estimates for each regional and country level market by treatment type.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global kidney stone management devices market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global kidney stone management devices market. This report concludes with company profiles section that highlights major information about the key players engaged in kidney stone management devices market.

Treatment Type Segmentation Investigation

Kidney stone presents the most common renal conditions with an incidence of two patients per 1,000 individuals. Increased obesity incidence, sedentary lifestyle, and growing prevalence of diabetes and hypertension are some of the common risk factors associated with kidney stone incidence and thus correspondingly growing patient pool. The risk of occurrence of kidney stone is also proportional to ageing; hence, aging population and growing life expectancy further aggravates the prevalence of the disease. Intracorporeal lithotripsy/uteroscopy has been gradually gaining prominence in the overall kidney stone management devices market, and is taking precedence over other treatment methods. Holmium laser-based stone removal procedure in uteroscopy is gaining prominence due to its relative safety against other conventional methods. Holmium laser stone removal procedure also avoids use of fragment collection tools such as baskets and lowers procedural duration, thus adding to the popularity of the procedure among both patients and surgeons.

Based on geography, the global kidney stone management devices market is currently led by North America and Europe, together taking approximately half market share in terms of revenue. Domicile of major market players in this region and rapid adoption of latest treatment technologies are the prime characteristics of these regions. Moreover, higher prevalence and recurrence rates of kidney stone in the domestic population, higher awareness among both patients and healthcare providers, and evolved reimbursement structure are the major factors driving the North America and Europe kidney stone management devices markets. The prevalence of kidney stone is much higher in Asia and Middle East regions. This phenomenon has been significantly responsible for the higher CAGRs in Asia-Pacific, and Middle East and Africa markets. Growing medical tourism, swift development of healthcare infrastructure and growing awareness are the major drivers facilitating the growth of kidney stone management devices in Asia-Pacific, Middle East and Africa, and Latin America markets.   

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Kidney Stone Management Devices market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Kidney Stone Management Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Treatment Type
  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Intracorporeal Lithotripsy
  • Percutaneous Nephrolithotomy (PCNL)
  • Accessories

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Kidney Stone Management Devices market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Kidney Stone Management Devices market?
  • Which is the largest regional market for Kidney Stone Management Devices market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Kidney Stone Management Devices market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Kidney Stone Management Devices market worldwide?
Choose Licence Type
$4325
$6325
$8325
Why Acute
View Other Reports